ABC | Volume 111, Nº2, Agosto 2018

Posicionamento 1º Posicionamento Brasileiro sobre o Impacto dos Distúrbios de Sono nas Doenças Cardiovasculares da Sociedade Brasileira de Cardiologia Arq Bras Cardiol. 2018; 111(2):290-340 167. Bitter T, Westerheide N, Prinz C, Hossain MS, Vogt J, Langer C, et al. Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure. Eur Heart J. 2011;32(1):61-74. doi: 10.1093/eurheartj/ehq327 168. Ryan CM, Usui K, Floras JS, Bradley TD. Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea. Thorax. 2005;60(9):781-5. doi: 10.1136/ thx.2005.040972. 169. Yumino D, Kasai T, Kimmerly D, Amirthalingam V, Floras JS, Bradley TD. Differing Effects of Obstrutive and Central Sleep Apneas on Stroke Volume in Patients with Heart Failure. Am J Respir Crit Care Med. 2012;187(4):433-43. doi: 10.1164/rccm.201205-0894OC. 170. Laaban JP, Pascal-Sebaoun S, Bloch E, Orvoen-Frija E, Oppert JM, Huchon G. Left ventricular systolic dysfunction in patients with obstructive sleep apnea syndrome. Chest. 2002;122(4):1133-8. PMID: 12377833. 171. Drager LF, Bortolotto LA, Figueiredo AC, Silva BC, Krieger EM, Lorenzi- Filho G. Obstructive sleep apnea, hypertension, and their interaction on arterial stiffness and heart remodeling. Chest. 2007;131(5):1379-86. doi: 10.1378/chest.06-2703. 172. Bradley TD, Hall MJ, Ando S, Floras JS. Hemodynamic effects of simulated obstructive apneas in humans with and without heart failure. Chest. 2001;119(6):1827-35. PMID: 11399711. 173. Ross J Jr. Afterload mismatch and preload reserve: a conceptual frameworkfor the analysis of ventricular function. Prog Cardiovasc Dis. 1976;18(4):255-264. PMID: 128034. 174. Svanborg E, Carlsson-Nordlander B, Larsson H, Sachs C, Kaijser L. Autonomic nervous system function in patients with primary obstructive sleep apnoea syndrome. Clin Auton Res. 1991;1(2):125-30. PMID: 1822759. 175. Carlson JT, Hedner JA, Sellgren J, ElamM,Wallin BG. Depressed baroreflex sensitivity in patients with obstructive sleep apnea. Am J Respir Crit Care Med. 1996;154(5):1490-6. doi: 10.1164/ajrccm.154.5.8912770. 176. Somers VK, Mark AL, Zavala DC, Abboud FM. Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans. J Appl Physiol (1985). 1989;67(5):2101-6. PMID: 2513316. 177. ChamiHA,DevereuxRB,Gottdiener JS,MehraR,RomanMJ,BenjaminEJ, et al. Left ventricular morphology and systolic function in sleep-disordered breathing: the SleepHeart Health Study. Circulation. 2008;117(20):2599- 607. doi: 10.1161/CIRCULATIONAHA.107.717892. 178. Varol E, Akcay S, Ozaydin M, Ozturk O, Cerci SS, Sahin U. Influence of obstructive sleep apnea on left ventricular mass and global function: sleep apneaandmyocardialperformance index.HeartVessels.2010;25(5):400- 4. doi: 10.1007/s00380-009-1225-3. 179. Romero-Corral A, Somers VK, Pellikka PA, Olson EJ, Bailey KR, Korinek J, et al. Decreased right and left ventricular myocardial performance in obstructive sleep apnea. Chest. 2007;132(6):1863-70. doi: 10.1378/ chest.07-0966. 180. Cho KI, Kwon JH, Kim SM, Park TJ, Lee HG, Kim TI. Impact of obstructive sleep apnea on the global myocardial performance beyond obesity. Echocardiography. 2012;29(9):1071-80. doi: 10.1111/j.1540- 8175.2012.01762.x. 181. Moro JA, Almenar L, Fernández-Fabrellas E, Ponce S, Blanquer R, Salvador A. Hypertension and sleep apnea-hypopnea syndrome: changes in echocardiographic abnormalities depending on the presence of hypertension and treatment with CPAP. Sleep Med. 2009;10(3):344-52. doi: 10.1016/j.sleep.2008.03.008. 182. DursunogluN,DursunogluD,OzkurtS,KuruO,GürS,KiterG,etal.Effects of CPAP on left ventricular structure andmyocardial performance index in male patients with obstructive sleep apnoea. SleepMed. 2007;8(1):51-9. doi: 10.1016/j.sleep.2006.04.007. 183. MaloneS,LiuPP,HollowayR,RutherfordR,XieA,BradleyTD.Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure. Lancet. 1991;338(8781):1480-4. PMID: 1683918. 184. KanekoY,FlorasJS,UsuiK,PlanteJ,TkacovaR,KuboT,etal.Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med. 2003;348(13):1233-41. doi: 10.1056/NEJMoa022479. 185. JavaheriS,CarefEB,ChenE,TongKB,AbrahamWT.Sleepapneatestingand outcomes in a large cohort of Medicare beneficiaries with newlydiagnosed heart failure. Am J Respir Crit Care Med. 2011;183(4):539-46. doi: 10.1164/rccm.201003-0406OC. 186. KhayatR, JarjouraD,PorterK,SowA,Wannemacher J,DoharR,etal.Sleep disordered breathing and post-discharge mortality in patients with acute heart failure. Eur Heart J. 2015;36(23):1463-9. doi: 10.1093/eurheartj/ ehu522. 187. Hedner J, Ejnell H, Caidahl K. Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnea. J Hypertens. 1990;8(10):941-6. PMID: 2174947. 188. Noda A, Okada T, Yasuma F, NakashimaN, YokotaM. Cardiac hypertrophy in obstructive sleep apnea syndrome. Chest. 1995;107(6):1538-44. PMID: 7781343. 189. Sukhija R, Aronow WS, Sandhu R, Kakar P, Maguire GP, Ahn C, et al. Prevalence of left ventricularhypertrophy in persons with and without obstructive sleep apnea. Cardiol Rev. 2006;14(4):170-2. doi: 10.1097/01. crd.0000184455.52778.00. 190. Baguet JP, Nadra M, Barone-Rochette G, Ormezzano O, Pierre H, Pépin JL. Early cardiovascular abnormalities in newly diagnosed obstructive sleep apnea. Vasc Health Risk Manag. 2009;5:1063-73. PMID: 20057899. 191. Cioffi G, Russo TE, Stefenelli C, Selmi A, Furlanello F, Cramariuc D, et al. Severe obstructive sleep apnea elicits concentric left ventricular geometry. J Hypertens. 2010;28(5):1074-82. PMID: 20411620. 192. Hla KM, Young T, Finn LA, Peppard PE, Kinsey TJ, Ende D. Electrocardiographically indicated cardiovascular disease in sleep- disordered breathing. Sleep Breath. 2008;12(3):251-8. doi: 10.1007/ s11325-007-0168-0. 193. Koga S, Ikeda S, Nakata T, Yasunaga T, Maemura K. Effects of nasal continuous positive airway pressure on left ventricular concentric hypertrophy in obstructive sleep apnea syndrome. Intern Med. 2012;51(20):2863-8. PMID: 23064559. 194. Shivalkar B, Van de Heyning C, Kerremans M, Rinkevich D, Verbraecken J, De Backer W, et al. Obstructive sleep apnea syndrome: more insights on structural and functional cardiac alterations, and the effects of treatment with continuous positive airway pressure. J Am Coll Cardiol. 2006;47(7):1433-9. doi: 10.1016/j.jacc.2005.11.054. 195. Cloward TV, Walker JM, Farney RJ, Anderson JL. Left ventricular hypertrophy is a common echocardiographic abnormality in severe obstructive sleep apnea and reverses with nasal continuous positive airway pressure. Chest. 2003;124(2):594-601. PMID: 12907548. 196. Usui Y, Takata Y, Inoue Y, Tomiyama H, Kurohane S, Hashimura Y, et al. Severe obstructive sleep apnea impairs left ventricular diastolic function in non-obese men. Sleep Med. 2013;14(2):155-9. doi: 10.1016/j. sleep.2010.09.014. 197. Yang SQ, Han LL, Dong XL, Wang CY, Xia H, Liu P, et al. Mal-effects of obstructive sleep apnea on the heart. Sleep Breath. 2012;16(3):717-22. doi: 10.1007/s11325-011-0566-1. 198. Cicek D, Lakadamyali H, Yağbasan BD, Sapmaz I, Müderrisoğlu H. Obstructive sleep apnoea and its association with left ventricular function and aortic root parameters in newly diagnosed, untreated patients: a prospective study. J Int Med Res. 2011;39(6):2228-38. doi: 10.1177/147323001103900619. 330